Which Patients First? Setting Priorities for Antiretroviral Therapy Where Resources Are Limited
Identifieur interne : 000A96 ( Pmc/Corpus ); précédent : 000A95; suivant : 000A97Which Patients First? Setting Priorities for Antiretroviral Therapy Where Resources Are Limited
Auteurs : Laura J. Mcgough ; Steven J. Reynolds ; Thomas C. Quinn ; Jonathan M. ZenilmanSource :
- American Journal of Public Health [ 0090-0036 ] ; 2005.
Abstract
The availability of limited funds from international agencies for the purchase of antiretroviral (ARV) treatment in developing countries presents challenges, especially in prioritizing who should receive therapy. Public input and the protection of human rights are crucial in making treatment programs equitable and accountable. By examining historical precedents of resource allocation, we aim to provoke and inform debate about current ARV programs.
Through a critical review of the published literature, we evaluate 4 precedents for key lessons: the discovery of insulin for diabetes in 1922, the release of penicillin for civilian use in 1943, the development of chronic hemodialysis programs in 1961, and current allocation of liver transplants. We then describe current rationing mechanisms for ARVs.
Url:
DOI: 10.2105/AJPH.2004.052738
PubMed: 15983271
PubMed Central: 1449336
Links to Exploration step
PMC:1449336Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Which Patients First? Setting Priorities for Antiretroviral Therapy Where Resources Are Limited</title><author><name sortKey="Mcgough, Laura J" sort="Mcgough, Laura J" uniqKey="Mcgough L" first="Laura J." last="Mcgough">Laura J. Mcgough</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author><author><name sortKey="Reynolds, Steven J" sort="Reynolds, Steven J" uniqKey="Reynolds S" first="Steven J." last="Reynolds">Steven J. Reynolds</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author><author><name sortKey="Quinn, Thomas C" sort="Quinn, Thomas C" uniqKey="Quinn T" first="Thomas C." last="Quinn">Thomas C. Quinn</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author><author><name sortKey="Zenilman, Jonathan M" sort="Zenilman, Jonathan M" uniqKey="Zenilman J" first="Jonathan M." last="Zenilman">Jonathan M. Zenilman</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">15983271</idno><idno type="pmc">1449336</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1449336</idno><idno type="RBID">PMC:1449336</idno><idno type="doi">10.2105/AJPH.2004.052738</idno><date when="2005">2005</date><idno type="wicri:Area/Pmc/Corpus">000A96</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000A96</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Which Patients First? Setting Priorities for Antiretroviral Therapy Where Resources Are Limited</title><author><name sortKey="Mcgough, Laura J" sort="Mcgough, Laura J" uniqKey="Mcgough L" first="Laura J." last="Mcgough">Laura J. Mcgough</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author><author><name sortKey="Reynolds, Steven J" sort="Reynolds, Steven J" uniqKey="Reynolds S" first="Steven J." last="Reynolds">Steven J. Reynolds</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author><author><name sortKey="Quinn, Thomas C" sort="Quinn, Thomas C" uniqKey="Quinn T" first="Thomas C." last="Quinn">Thomas C. Quinn</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author><author><name sortKey="Zenilman, Jonathan M" sort="Zenilman, Jonathan M" uniqKey="Zenilman J" first="Jonathan M." last="Zenilman">Jonathan M. Zenilman</name><affiliation><nlm:aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</nlm:aff></affiliation></author></analytic><series><title level="j">American Journal of Public Health</title><idno type="ISSN">0090-0036</idno><idno type="eISSN">1541-0048</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The availability of limited funds from international agencies for the purchase of antiretroviral (ARV) treatment in developing countries presents challenges, especially in prioritizing who should receive therapy. Public input and the protection of human rights are crucial in making treatment programs equitable and accountable. By examining historical precedents of resource allocation, we aim to provoke and inform debate about current ARV programs.</p><p>Through a critical review of the published literature, we evaluate 4 precedents for key lessons: the discovery of insulin for diabetes in 1922, the release of penicillin for civilian use in 1943, the development of chronic hemodialysis programs in 1961, and current allocation of liver transplants. We then describe current rationing mechanisms for ARVs.</p></div></front></TEI><pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Am J Public Health</journal-id><journal-id journal-id-type="publisher-id">ajph</journal-id><journal-title>American Journal of Public Health</journal-title><issn pub-type="ppub">0090-0036</issn><issn pub-type="epub">1541-0048</issn><publisher><publisher-name>© American Journal of Public Health 2005</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15983271</article-id><article-id pub-id-type="pmc">1449336</article-id><article-id pub-id-type="publisher-id">0951173</article-id><article-id pub-id-type="doi">10.2105/AJPH.2004.052738</article-id><article-categories><subj-group subj-group-type="heading"><subject>Public Health Matters</subject></subj-group></article-categories><title-group><article-title>Which Patients First? Setting Priorities for Antiretroviral Therapy Where Resources Are Limited</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>McGough</surname><given-names>Laura J.</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Reynolds</surname><given-names>Steven J.</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Quinn</surname><given-names>Thomas C.</given-names></name><degrees>MD, MS</degrees><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Zenilman</surname><given-names>Jonathan M.</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">At the time this article was written, all authors were with the Department of Infectious Diseases, Johns Hopkins University, Baltimore, Md. Laura J. McGough is also with the Department of the History of Medicine, Johns Hopkins University. Steven J. Reynolds and Thomas C. Quinn are also with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</aff><author-notes><fn><p><italic>Requests for reprints should be sent to Jonathan M. Zenilman, MD, Infectious Diseases Division, Johns Hopkins Bayview Medical Center, 4940 Eastern Ave, B-3 North, Baltimore, MD 21224 (e-mail: <email>jzenilma@jhmi.edu</email>).</italic></p></fn></author-notes><pub-date pub-type="ppub"><month>7</month><year>2005</year></pub-date><volume>95</volume><issue>7</issue><fpage>1173</fpage><lpage>1180</lpage><history><date date-type="accepted"><day>30</day><month>1</month><year>2005</year></date></history><copyright-statement>© American Journal of Public Health 2005</copyright-statement><copyright-year>2005</copyright-year><abstract><p>The availability of limited funds from international agencies for the purchase of antiretroviral (ARV) treatment in developing countries presents challenges, especially in prioritizing who should receive therapy. Public input and the protection of human rights are crucial in making treatment programs equitable and accountable. By examining historical precedents of resource allocation, we aim to provoke and inform debate about current ARV programs.</p><p>Through a critical review of the published literature, we evaluate 4 precedents for key lessons: the discovery of insulin for diabetes in 1922, the release of penicillin for civilian use in 1943, the development of chronic hemodialysis programs in 1961, and current allocation of liver transplants. We then describe current rationing mechanisms for ARVs.</p></abstract></article-meta><notes><fn-group><fn><p>Peer Reviewed</p></fn><fn><p><bold>Contributors</bold>
L. J. McGough conceived the study and led the research and writing. S. J. Reynolds and T. C. Quinn offered technical advice and analysis. J. M. Zenilman supervised the entire process of analysis and article preparation. All authors helped to conceptualize ideas, interpret findings, and revise drafts of the article.</p></fn></fn-group></notes></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A96 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000A96 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:1449336
|texte= Which Patients First? Setting Priorities for Antiretroviral Therapy Where Resources Are Limited
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:15983271" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |